@OpenAI: GPT-Rosalind, our Life Sciences model series, is optimized for scientific workflows, with stronger performance in prote…
Summary
OpenAI releases GPT-Rosalind, a specialized life sciences model optimized for protein reasoning, chemical analysis, genomics, and scientific workflows.
View Cached Full Text
Cached at: 04/20/26, 09:39 AM
GPT-Rosalind, our Life Sciences model series, is optimized for scientific workflows, with stronger performance in protein and chemical reasoning, genomics analysis, biochemistry knowledge, and scientific tool use.
Similar Articles
Introducing GPT-Rosalind for life sciences research
OpenAI introduces GPT-Rosalind, a frontier reasoning model designed to accelerate research in biology, drug discovery, and translational medicine by optimizing scientific workflows and tool usage.
Introducing new capabilities to GPT-Rosalind
OpenAI introduces an updated GPT-Rosalind model purpose-built for life sciences research, with improved performance in medicinal chemistry, genomics, and drug-discovery workflows, and new benchmarks like LifeSciBench and MedChemBench.
@OpenAI: Introducing GPT-Rosalind, our frontier reasoning model built to support research across biology, drug discovery, and tr…
OpenAI introduces GPT-Rosalind, a frontier reasoning model specifically designed to support research in biology, drug discovery, and translational medicine.
Designing faster life sciences experiments
OpenAI’s GPT-Rosalind plus a Life-Sciences Research Plugin turns a high-priority target into a ready-to-run 96-well wet-lab protocol in seconds, grounding every reagent choice in public data and feeding results back to shorten design cycles to hours.
Turning scattered evidence into discovery decisions for life sciences
OpenAI’s new life-science model “GPT-Rosalind” inside Codex autonomously ranks asthma drug targets by orchestrating specialist sub-agents that merge genetics, transcriptomics, safety and IP data into a single evidence-backed decision.